Home Cart Sign in  
Chemical Structure| 36703-88-5 Chemical Structure| 36703-88-5

Structure of Inosine Pranobex
CAS No.: 36703-88-5

Chemical Structure| 36703-88-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isoprinosine is a nucleoside, an alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections.

Synonyms: Isoprinosine; Imunovir; NPT 10381

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Inosine Pranobex

CAS No. :36703-88-5
Formula : C52H78N10O17
M.W : 1115.23
SMILES Code : O=C1C(N=CN2[C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)=C2NC=N1.OC(C4=CC=C(NC(C)=O)C=C4)=O.CN(CC(O)C)C.CN(CC(O)C)C.CN(CC(O)C)C.OC(C5=CC=C(NC(C)=O)C=C5)=O.OC(C6=CC=C(NC(C)=O)C=C6)=O
Synonyms :
Isoprinosine; Imunovir; NPT 10381
MDL No. :MFCD05662374
InChI Key :YLDCUKJMEKGGFI-QCSRICIXSA-N
Pubchem ID :135449284

Safety of Inosine Pranobex

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Porcine peripheral blood mononuclear cells (PBMCs) 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on porcine PBMCs, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. PMC10951065
Murine peritoneal exudate cells (PECs) 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on murine PECs, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. PMC10951065
ZZ-R cells 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on ZZ-R cells, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. PMC10951065
LF-BK cells 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on LF-BK cells, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. PMC10951065
BHK-21 cells 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on BHK-21 cells, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. PMC10951065
HEK293T cells 0.25, 1, or 2 mM 48 h IP treatment led to a significant increase in cell surface MICA expression PMC6972573
ZZ-R cells 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL PMC10951065
LF-BK cells 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL PMC10951065
BHK-21 cells 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL PMC10951065
Porcine peripheral blood mononuclear cells (PBMCs) 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL PMC10951065
Murine peritoneal exudate cells (PECs) 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL PMC10951065

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Foot-and-mouth disease virus infection model Intramuscular injection 100 mg/mouse Single injection, monitored for 7 days Evaluate the host defense effect of isoprinosine alone against FMDV infection in mice, showing no protection when administered alone. PMC10951065
Mice FMDV infection model Intramuscular injection 100 mg/mouse Single injection, monitored up to 7 days post-challenge Evaluated the host defense effect of isoprinosine alone against FMDV infection, showing no protective effect PMC10951065
Hamsters Aging hamster model Intraperitoneal injection 5 mg/kg Single injection or weekly injections for continuous treatment To study the restorative effect of ISO on immune functions in aging hamsters, results showed that a single injection of ISO significantly increased lymphocyte proliferation, NK cell activity, and monocyte chemotaxis, while continuous treatment maintained these immune parameters near the levels found in young adult hamsters. PMC370380

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00000699 HIV Infections Phase 1 Completed - United States, District of Col... More >>umbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 Less <<
NCT00002295 HIV Infections Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002061 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002296 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002059 HIV Infections Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002060 HIV Infections Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002297 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.90mL

0.18mL

0.09mL

4.48mL

0.90mL

0.45mL

8.97mL

1.79mL

0.90mL

References

 

Historical Records

Categories